To explore further the clinical relevance of GSDMB expression in breast cancer, we realized an in silico study combining six breast cancer profiling datasets performed on the HG-U133A Affymetrix microarray platform [18]–[23]. The gene discussed is GSDMB; the disease is breast carcinoma.